Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

Completed the sale of FibroGen China to AstraZeneca for approximately $220 millionInitiated the Phase 2 monotherapy trial of FG-3246, a potential ...

First American Nuclear has announced plans to build an energy park in Indiana, featuring its EAGL-1 lead-bismuth fast reactor ...

If there is no category where the subscription model feels most greedy, it’s password management. Services like 1Password and ...

We spoke with Eugene Amigud, Chief Innovation Officer at Infios, following the company's newly announced collaboration with Amazon Web Services (AWS) aimed at transforming supply chain execution with ...

Thank you. Good afternoon, and welcome to Viant Technologies Third Quarter 2025 Earnings Conference Call. On the call today are Tim Vanderhook, Co-Founder and Chief Executive Officer; Chris Vanderhook ...

Bakkt Holdings, Inc. ( BKKT) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Greetings, and welcome to the Bakkt's Third Quarter 2025 Earnings Conference Call. [Operator Instructions]. As a ...

EVerZom's investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative therapies Pending successful in vivo proof-o ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

Workhorse Group, Inc. (Nasdaq: WKHS) ('Workhorse” or 'the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial ...

The proposal from developer JPP includes 10 affordable homes, garages, two new access points, parking, and public open space.

Now, researchers from the Nanjing University of Aeronautics and Astronautics have developed a new solution, a floating DEG ...